Article info

Download PDFPDF
Combretastatin A-1 phosphate potentiates the antitumor activity of carboplatin and paclitaxel in a severe combined immunodeficiency disease (SCID) mouse model of human ovarian carcinoma

Authors

  1. Address correspondence and reprint request to: Paivi Kannisto, MD, PhD, Department of Obstetrics and Gynecology, University Hospital of Lund, 22185 Lund, Sweden. Email: paivi.kannisto{at}med.lu.se

Citation

Staflin K, Järnum S, Hua J, et al
Combretastatin A-1 phosphate potentiates the antitumor activity of carboplatin and paclitaxel in a severe combined immunodeficiency disease (SCID) mouse model of human ovarian carcinoma

Publication history

  • First published July 1, 2006.
Online issue publication 
July 01, 2006

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.